Zobrazeno 1 - 10
of 85
pro vyhledávání: '"Catherine M Viscoli"'
Autor:
Rachel Forman, Catherine M Viscoli, Katherine Meurer, Kevin N Sheth, Lauren H Sansing, Adam de Havenon, Richa Sharma, Melissa Mariscal, Walter N Kernan
Publikováno v:
American Journal of Hypertension. 36:195-200
BackgroundIn individuals with hypertension (HTN), lowering blood pressure (BP) after a stroke can lower the risk of stroke recurrence, but many patients do not reach the goal. Home blood pressure monitoring (HBPM) can help patients get to the goal, b
Autor:
Samer F. Hassan, Catherine M. Viscoli, Patrick G. O’Connor, Lydia S. Dugdale, Andre N. Sofair, Matthew M. Fitz, Bradley Richards, Kirsten B. Feiereisel, Susan Y. Lee, Shelley R. Ost, Jennifer L. Swails, Mary B. Fishman, Walter N. Kernan
Publikováno v:
Journal of General Internal Medicine.
Autor:
Silvio E. Inzucchi, Amber Stuart, Peter D. Guarino, Karen L. Furie, David M. Kent, Jennifer L. Dearborn, Mark Gorman, Lawrence H. Young, Walter N. Kernan, Robin Conwit, Catherine M. Viscoli
Publikováno v:
Stroke
Background and Purpose— The insulin sensitizer, pioglitazone, reduces cardiovascular risk in patients after an ischemic stroke or transient ischemic attack but increases bone fracture risk. We conducted a secondary analysis of the IRIS trial (Insul
Autor:
Rachel Forman, Catherine M. Viscoli, Philip M. Bath, Karen L. Furie, Peter Guarino, Silvio E. Inzucchi, Lawrence Young, Walter N. Kernan
Publikováno v:
Journal of Stroke and Cerebrovascular Diseases. 31:106667
Central adjudication of outcome events is the standard in clinical trial research. We examine the benefit of central adjudication in the Insulin Resistance Intervention after Stroke (IRIS) trial and show how the benefit is influenced by outcome defin
Publikováno v:
J Stroke Cerebrovasc Dis
Objective Standards for reporting and analyzing adherence to medical therapy have recently improved due to international consensus efforts. If applied to clinical trial research in patients with stroke, these improvements have the potential to identi
Autor:
Catherine M. Viscoli, Anne M. Lovejoy, Erica S. Spatz, Daniel Jacoby, Steven Pfau, Silvio E. Inzucchi, Gregory G. Schwartz, J. Dawn Abbott, Frederick S. Ling, Walter N. Kernan, Lawrence H. Young, Jeptha P. Curtis, Daniel M. Kolansky, Robin Conwit, Karen L. Furie, Mark Gorman
Publikováno v:
Circulation. 138:1210-1220
Background: The IRIS trial (Insulin Resistance Intervention After Stroke) demonstrated that pioglitazone reduced the risk for both cardiovascular events and diabetes mellitus in insulin-resistant patients. However, concern remains that pioglitazone m
Autor:
Mark Gorman, Linnea A. Polgreen, Catherine M. Viscoli, Enrique C. Leira, Walter N. Kernan, collab
Publikováno v:
Neuroepidemiology. 50:137-143
Background and Purpose: Clinical trials often seek to enroll patients from both urban and rural areas to safeguard the generalizability of results. However, maintaining contact with patients who live away from a recruitment site, including rural area
Autor:
Karen L. Furie, Peter D. Guarino, David Tanne, Catherine M. Viscoli, Silvio E. Inzucchi, Anne M. Lovejoy, Mark Gorman, Lawrence H. Young, Walter N. Kernan, Robin Conwit, Gary A. Ford
Publikováno v:
Journal of Neurology, Neurosurgery & Psychiatry. 89:21-27
IntroductionPatients with cerebrovascular disease are at increased risk for cognitive dysfunction. Modification of vascular risk factors, including insulin resistance, could improve poststroke cognitive function.MethodsIn the Insulin Resistance Inter
Autor:
Katherine A, Epstein, Catherine M, Viscoli, J David, Spence, Lawrence H, Young, Silvio E, Inzucchi, Mark, Gorman, Brett, Gerstenhaber, Peter D, Guarino, Anand, Dixit, Karen L, Furie, Walter N, Kernan, Howard S, Kirshner
Publikováno v:
Department of Medicine Publications
Objective:To assess whether smoking cessation after an ischemic stroke or TIA improves outcomes compared to continued smoking.Methods:We conducted a prospective observational cohort study of 3,876 nondiabetic men and women enrolled in the Insulin Res